A carregar...

Inhibition of STAT3 activity re-activates anti-tumor immunity but fails to restore the immunogenicity of tumor cells in a B-cell lymphoma model

A large number of patients with advanced lymphoma become refractory or relapse after initial treatment due to the persistence of minimal residual disease. Ideal immunotherapy strategy for eradicating the minimal residual disease of lymphoma and preventing the tendency to relapse need to be developed...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Cao, Yang, Zhou, Xiaoxi, Zhou, Mi, Xu, Danmei, Ma, Quanfu, Zhang, Peilin, Huang, Xiaoyuan, Li, Qinlu, Ma, Ding, Zhou, Jianfeng
Formato: Artigo
Idioma:Inglês
Publicado em: Landes Bioscience 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4128858/
https://ncbi.nlm.nih.gov/pubmed/24915165
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cbt.29453
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!